QA: Akorn INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2012_Akorn_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000003116, Akorn INC

  xvar xval
0 AssetsCurrent 155,949,000
1 IntangibleAssetsNetIncludingGoodwill 79,685,000
2 PropertyPlantAndEquipmentNet 44,389,000
3 remainder_Assets 27,122,000
4 LiabilitiesCurrent 28,289,000
5 LiabilitiesNoncurrent 120,648,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 57,231,000
8 SellingGeneralAndAdministrativeExpense 33,135,000
9 ResearchAndDevelopmentExpense 11,555,000
10 remainder_Expenses 1,974,000
11 remainder_Revenues 136,920,000
12 remainder_NetIncome 12,267,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 307,145,000
1 Liabilities 148,937,000
2 Expenses 103,895,000
3 Revenues 136,920,000
4 StockholdersEquity 158,208,000
5 NetIncome 45,292,000
6 ComprehensiveNetIncome 45,292,000
7 BaseVar 354,582,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.71
9 EconomicCapitalRatio 2.83

Edgar->Model Mapping

Feature Distribution